Fedratinib - Celgene Corporation
At a glance
- Drug Originator TargeGen
- Drug Licenced by Celgene Corporation
- Drug Class Antifibrotics; Antihaemorrhagics; Antineoplastics; Phenyl ethers; Pyrimidines; Pyrrolidines; Small molecules; Sulfonamides
- Mechanism of Action Fms-like tyrosine kinase 3 inhibitors; Janus kinase 2 inhibitors
- USA Patent Applicants BRISTOL-MYERS
- USA Patents 7
- NDAs 1
- International Patents 113
- Patent Applications 361
Table of Contents

Disclaimer